Interpretation of serial interferon-gamma test results to measure new tuberculosis infection among household contacts in Zambia and South Africa

[1] Rangaka MX(2012)Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis Lancet Infect Dis 12 45-55

[2] Wilkinson KA(2015)TBNET. Risk assessment of tuberculosis in contacts by IFN-gamma release assays Am J Respir Crit Care Med 191 1176-1184

[3] Glynn JR(2005)Diagnosis of latent mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent? Expert Rev Anti-Infect Ther 3 981-993

[4] Ling D(2005)Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention. Guidelines for using the QuantiFERON-TB Gold test for detecting MMWR Recomm Rep 54 49-55

[5] Menzies D(2012) infection, United States Am J Respir Crit Care Med 186 1051-1056

[6] Mwansa-Kambafwile J(2017)Predictive value of recent QuantiFERON conversion for tuberculosis disease in adolescents Lancet Respir Med 5 282-290

[7] Zellweger JP(2014)Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study Clin Microbiol Rev 27 3-20

[8] Sotgiu G(2014)Gamma interferon release assays for detection of mycobacterium tuberculosis infection Am J Respir Crit Care Med 189 77-87

[9] Block M(2014)Tuberculosis epidemiologic studies consortium. Interferon-g release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States Ann Am Thorac Soc 11 296-302

[10] Dore S(2008)IFN-g release assay conversions and reversions. Challenges with serial testing in U.S. health care workers PLoS One 3 1366-1368

[1] Rangaka MX(2012)Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis Lancet Infect Dis 12 45-55

[2] Wilkinson KA(2015)TBNET. Risk assessment of tuberculosis in contacts by IFN-gamma release assays Am J Respir Crit Care Med 191 1176-1184

[3] Glynn JR(2005)Diagnosis of latent mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent? Expert Rev Anti-Infect Ther 3 981-993

[4] Ling D(2005)Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention. Guidelines for using the QuantiFERON-TB Gold test for detecting MMWR Recomm Rep 54 49-55

[5] Menzies D(2012) infection, United States Am J Respir Crit Care Med 186 1051-1056

[6] Mwansa-Kambafwile J(2017)Predictive value of recent QuantiFERON conversion for tuberculosis disease in adolescents Lancet Respir Med 5 282-290

[7] Zellweger JP(2014)Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study Clin Microbiol Rev 27 3-20

[8] Sotgiu G(2014)Gamma interferon release assays for detection of mycobacterium tuberculosis infection Am J Respir Crit Care Med 189 77-87

[9] Block M(2014)Tuberculosis epidemiologic studies consortium. Interferon-g release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States Ann Am Thorac Soc 11 296-302

[10] Dore S(2008)IFN-g release assay conversions and reversions. Challenges with serial testing in U.S. health care workers PLoS One 3 1366-1368